These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22389347)

  • 1. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
    BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Ortegón M; Lim S; Chisholm D; Mendis S
    BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Stanciole AE; Ortegón M; Chisholm D; Lauer JA
    BMJ; 2012 Mar; 344():e608. PubMed ID: 22389338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Chisholm D; Saxena S
    BMJ; 2012 Mar; 344():e609. PubMed ID: 22389339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
    Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
    Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Baltussen R; Smith A
    BMJ; 2012 Mar; 344():e615. PubMed ID: 22389341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of strategies to combat road traffic injuries in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Chisholm D; Naci H; Hyder AA; Tran NT; Peden M
    BMJ; 2012 Mar; 344():e612. PubMed ID: 22389340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
    Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA
    BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA).
    Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M
    Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of breast cancer control interventions in Peru.
    Zelle SG; Vidaurre T; Abugattas JE; Manrique JE; Sarria G; Jeronimo J; Seinfeld JN; Lauer JA; Sepulveda CR; Venegas D; Baltussen R
    PLoS One; 2013; 8(12):e82575. PubMed ID: 24349314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
    Mohan G; Chattopadhyay S
    JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness analysis of strategies for tuberculosis control in developing countries.
    Baltussen R; Floyd K; Dye C
    BMJ; 2005 Dec; 331(7529):1364. PubMed ID: 16282379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical models of cervical cancer prevention in the Asia Pacific region.
    Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
    Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of malaria control in sub-Saharan Africa.
    Goodman CA; Coleman PG; Mills AJ
    Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
    Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
    Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries.
    Adam T; Lim SS; Mehta S; Bhutta ZA; Fogstad H; Mathai M; Zupan J; Darmstadt GL
    BMJ; 2005 Nov; 331(7525):1107. PubMed ID: 16282407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative economics of screening for colorectal cancer, breast cancer and cervical cancer.
    Gyrd-Hansen D
    Crit Rev Oncol Hematol; 1999 Nov; 32(2):133-44. PubMed ID: 10612013
    [No Abstract]   [Full Text] [Related]  

  • 20. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.
    Eaton JW; Menzies NA; Stover J; Cambiano V; Chindelevitch L; Cori A; Hontelez JA; Humair S; Kerr CC; Klein DJ; Mishra S; Mitchell KM; Nichols BE; Vickerman P; Bakker R; Bärnighausen T; Bershteyn A; Bloom DE; Boily MC; Chang ST; Cohen T; Dodd PJ; Fraser C; Gopalappa C; Lundgren J; Martin NK; Mikkelsen E; Mountain E; Pham QD; Pickles M; Phillips A; Platt L; Pretorius C; Prudden HJ; Salomon JA; van de Vijver DA; de Vlas SJ; Wagner BG; White RG; Wilson DP; Zhang L; Blandford J; Meyer-Rath G; Remme M; Revill P; Sangrujee N; Terris-Prestholt F; Doherty M; Shaffer N; Easterbrook PJ; Hirnschall G; Hallett TB
    Lancet Glob Health; 2014 Jan; 2(1):e23-34. PubMed ID: 25104632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.